Pc 4 photodynamic therapy of U87-derived human glioma in the nude rat

Lasers in Surgery and Medicine

Volumn 36, Issue 5, 2005, Pages 383-389

  George III, John E ^a   Ahmad, Yusra ^a   Varghai, Davood ^a   Li, Xiaolin ^b   Berlin, Jeffrey ^a   Jackowe, David ^a   Jungermann, Marc ^a   Wolfe, Michael S ^a   Lilge, Lothar ^c   Totonchi, Ali ^a   Morris, Rachel L ^b   Peterson, Allyn ^a   Lust, W David ^a   Kenney, Malcolm E ^a   Hoppel, Charles L ^b   Sun, Jiayang ^a   Oleinick, Nancy L ^b   Dean, David ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Athymic; Biophotonics; Brain tumor; Cancer; Glioblastoma multiforme; Mass spectrometry; Photosensitizer; Phthalocyanine

Indexed keywords

PHOTOSENSITIZING AGENT; PHTHALOCYANINE 4; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; GLIOMA; NECROSIS; NONHUMAN; PHOTODYNAMIC THERAPY; PHOTOSENSITIZATION; PRIORITY JOURNAL; RAT; RAT STRAIN;

ANIMALS; BRAIN NEOPLASMS; CELL LINE, TUMOR; GLIOMA; HUMANS; INDOLES; INJECTIONS, INTRAVENOUS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; RATS; RATS, NUDE;

EID: 21744435559     PISSN: 01968092     EISSN: None     Source Type: Journal    
DOI: 10.1002/lsm.20185     Document Type: Article

References (41)

1. CBTRUS (Central Brain Tumor Registry of the US). 2002-2003. Primary Brain Tumors in the United States, Statistical Report (http://www.cbtrus.org/ factsheet.htm).
2. McLendon RE, Halperin EC. Is the long-term survival of patients with intracranial glioblastoma multiforme over-stated? Cancer 2003;98:1745-1748.
3. Rosenthal MA, Kavar B, Uren S, Kaye AH. Promising survival in patients with high-grade gliomas following therapy with a novel boronated porphyrin. J Clin Neurosci 2003;10: 425-427.
4. Schmidt MH, Meyer GA, Reichert KW, Cheng J, Krouwer HG, Ozker K, Whelan HT. Evaluation of photodynamic therapy near functional brain tissue in patients with recurrent brain tumors. J Neurooncol 2004;67:201-207.
5. Stummer W, Novotny A, Stepp H, Goetz C, Bise K, Reulen HJ. Fluorescence-guided resection of glioblastoma multiforme by using 5-aminolevulinic acid-induced porphyrins: A prospective study in 52 consecutive patients. J Neurosurg 2000;93:1003-1013.
6. Oleinick NL, Antunez AR, Clay ME, Rihter BD, Kenney ME. New phthalocyanine photosensitizers for photodynamic therapy. Photochem Photobiol 1993;57:242-247.
7. Weishaupt K, Gomer CJ, Dougherty T. Identification of singlet oxygen as the cytotoxic agent in photoinactivation of a murine tumor. Cancer Res 1976;36:2326-2329.
8. Moan J, Berg K. Photochemotherapy of cancer: Experimental research. Photochem Photobiol 1992;55:931-948.
9. Macdonald IJ, Dougherty TJ. Basic principles of photodynamic therapy. J Porphyrins and Phthalocyanines 2001;5: 105-129.
10. Oleinick NL, Morris RL, Belichenko I. The role of apoptosis in response to photodynamic therapy: What, where, why, and how. Photochem Photobiol Sci 2002;1:1-21.
11. Lam M, Oleinick NL, Nieminen AL. Photodynamic therapy-induced apoptosis in epidermoid carcinoma cells. Reactive oxygen species and mitochondrial inner membrane permeabilization. J Biol Chem 2001;276:47379-47386.
12. Gomer CJ. DNA damage and repair in CHO cells following hematoporphyrin photoradiation. Cancer Lett 1980;11:161-167.
13. Moan J, Waksvik H, Christensen T. DNA single-strand breaks and sister chromatid exchanges induced by treatment with hematoporphyrin and light or by X-rays in human NHIK 3025 cells. Cancer Res 1980;40:2915-2918.
14. Ramakrishnan N, Oleinick NL, Clay ME, Horng MF, Antunez AR, Evans HH. DNA lesions and DNA degradation in mouse lymphoma L5178Y cells after photodynamic treatment sensitized by chloroaluminum phthalocyanine. Photochem Photobiol 1989;50:373-378.
15. Gomer CJ, Rucker N, Murphree AL. Differential cell photosensitivity following porphyrin photodynamic therapy. Cancer Res 1988;48:4539-4542.
16. Wilson BC, Olivo M, Singh G. Subcellular localization of Photofrin and aminolevulinic acid and photodynamic cross-resistance in vitro in radiation-induced fibrosarcoma cells sensitive or resistant to photofrin-mediated photodynamic therapy. Photochem Photobiol 1997;65:166-176.
17. Trivedi NS, Wang HW, Nieminen AL, Oleinick NL, Izatt JA. Quantitative analysis of Pc 4 localization in mouse lymphoma (LY-R) cells via double-label confocal fluorescence microscopy. Photochem Photobiol 2000;71:634-639.
18. Morris RL, Varnes ME, Kenney ME, Li YS, Azizuddin K, McEnery MW, Oleinick NL. The peripheral benzodiazepine receptor in photodynamic therapy with the phthalocyanine photosensitizer Pc 4. Photochem Photobiol 2002;75:652-661.
19. Usuda J, Chiu SM, Murphy ES, Lam M, Nieminen AL, Oleinick NL. Domain-dependent photodamage to Bcl-2. A membrane anchorage region is needed to form the target of phthalocyanine photosensitization. J Biol Chem 2003;278: 2021-2029.
20. Xue LY, Chiu SM, Oleinick NL. Photochemical destruction of Bcl-2 oncoprotein during photodynamic therapy with the phthalocyanine photosensitizer Pc4. Oncogene 2001;20: 3420-3427.
21. Xue LY, Chiu SM, Fiebig A, Andrews DW, Oleinick NL. Photodamage to multiple Bcl-xL isoforms by photodynamic therapy with the phthalocyanine photosensitizer Pc 4. Oncogene 2003;22:9197-9204.
22. Fels C, Schafer C, Huppe B, Bahn H, Heidecke V, Kramm CM, Lautenschlager C, Rainov NG. Bcl-2 expression in higher-grade human glioma: A clinical and experimental study. J Neurooncol 2000;48:207-216.
23. Usuda J, Azizuddin K, Chiu SM, Oleinick NL. Association between the photodynamic loss of Bcl-2 and the sensitivity to apoptosis caused by phthalocyanine photodynamic therapy. Photochem Photobiol 2003;78:1-8.
24. Chiu SM, Xue LY, Usuda J, Azizuddin K, Oleinick NL. Bax is essential for mitochondrion-mediated apoptosis but not for cell death caused by photodynamic therapy. Br J Cancer 2003;89:1590-1597.
25. Morris RL, Azizuddin K, Lam M, Berlin J, Nieminen AL, Kenney ME, Samia AC, Burda C, Oleinick NL. Fluorescence resonance energy transfer reveals a binding site of a photosensitizer for photodynamic therapy. Cancer Res 2003;63: 5194-5197.
26. Lilge L, Wilson BC. Photodynamic therapy of intracranial tissues: A preclinical comparative study of four different photosensitizers. J Clin Laser Med Surg 1998;16: 81-91.
27. Lilge L, Portnoy M, Wilson BC. Apoptosis induced in vivo by photodynamic therapy in normal brain and intracranial tumour tissue. Br J Cancer 2000;83:1110-1117.
28. Lilge L, Ching E, Portnoy M, Molckovsky A, Wilson BC. Photofrin mediated PDT in normal rat brain: Assessment on apoptosis as a quantitative biological endpoint. In: Dougherty TJ, editor. Optical methods for tumor treatment and detection: Mechanisms and techniques in photodynamic therapy IX, Vol. 3909. Bellingham, WA: SPIE; 2000. 45-52.
29. Anderson C, Hrabovsky S, McKinley Y, Tubesing K, Tang HP, Dunbar R, Mukhtar H, Elmets CA. Phthalocyanine photodynamic therapy: Disparate effects of pharmacologic inhibitors on cutaneous photosensitivity and on tumor regression. Photochem Photobiol 1997;65:895-901.
30. Lilge L, Portnoy M, Wilson BC. PDT-induced apoptosis in brain tissue in vivo: Apoptosis following PDT in normal and VX2 tumor-bearing rabbit brain. In: Dougherty TJ, editor. Optical methods for tumor treatment and detection: Mechanisms nd techniques in photodynamic therapy VIII, Vol. 3592. Bellingham, WA: SPIE; 1999. 28-36.
31. Jiang F, Lilge L, Belcuig M, Singh G, Grenier J, Li Y, Chopp M. Photodynamic therapy using Photofrin in combination with buthionine sulfoximine (BSO) to treat 9L gliosarcoma in rat brain. Lasers Surg Med 1998;23:161-166.
32. Rainov NG, Koch S, Sena-Esteves M, Berens ME. Characterization of a canine glioma cell line as related to established experimental brain tumor models. J Neuropathol Exp Neurol 2000;59:607-613.
33. Saini M, Bellinzona M, Meyer F, Cali G, Samii M. Morphometrical characterization of two glioma models in the brain of immunocompetent and immunodeficient rats. J Neurooncol 1999;42:59-67.
34. Stummer W, Stocker S, Novotny A, Heimann A, Sauer O, Kempski O, Plesnila N, Wietzorrek J, Reulen HJ. In vitro and in vivo porphyrin accumulation by C6 glioma cells after exposure to 5-aminolevulinic acid. J Photochem Photobiol B 1998;45:160-169.
35. Obwegeser A, Jakober R, Kostron H. Uptake and kinetics of 14C-labelled meta-tetrahydroxyphenylchlorin and 5-aminolaevulinic acid in the C6 rat glioma model. Br J Cancer 1998;78:733-738.
36. Hebeda KM, Saarnak AE, Olivo M, Sterenborg HJ, Wolbers JG. 5-Aminolevulinic acid induced endogenous porphyrin fluorescence in 9L and C6 brain tumours and in the normal rat brain. Acta Neurochir (Wien) 1998;140(5):503-512; discussion 512-513.
37. Erratum in: Acta Neurochir (Wien) 1998; 140(8):881.
38. Jiang F, Robin AM, Katakowski M, Tong L, Espiritu M, Singh G, Chopp M. Photodynamic therapy with photofrin in combination with buthionine sulfoximine (BSO) of human glioma in the nude rat. Lasers Med Sci 2003;18:128-133.
39. Engebraaten O, Hjortland GO, Hirschberg H, Fodstad O. Growth of precultured human glioma specimens in nude rat brain. J Neurosurg 1999;90:125-132.
40. Deisboeck TS, Berens ME, Kansal AR, Torquato S, Stemmer-Rachamimov AO, Chiocca EA. Pattern of self-organization in tumour systems: Complex growth dynamics in a novel brain tumour spheroid model. Cell Prolif 2001;34:115-134.
41. Lobel J, MacDonald IJ, Ciesielski MJ, Barone T, Potter WR, Pollina J, Plunkett RJ, Fenstermaker RA, Dougherty TJ. 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a (HPPH) in a nude rat glioma model: Implications for photodynamic therapy. Lasers Surg Med 2001;29:397-405.